Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 17, 235-239, April 1, 1957]
© 1957 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ball, H. A.
Right arrow Articles by Sanders, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ball, H. A.
Right arrow Articles by Sanders, C.

Influence of Glucose Antimetabolites on the Walker Tumor*

Howard A. Ball, Arne N. Wick and Curtis Sanders

( Biological Research Institute, San Diego Zoological Society, San Diego, and Scripps Clinic and Research Foundation, La Jolla, Calif.)

1. The intraperitoneal, divided-dose administration of glucosamine hydrochloride, 400–600 mg/rat/day (approximates 2,000–3,000 mg/kg/day) or 2-deoxy-D-glucose 200 mg/rat/day (approximates 1,000 mg/kg/day) exerted an antitumor effect in rats bearing Walker 256 tumor, without seriously compromising the general well being of the host.
2. The antitumor effect of 2DG was somewhat greater than that of glucosamine at 1/21/3 the glucosamine dosage level.
3. Changes in rate of tumor growth between treatment and nontreatment periods were significant when 2DG was used.
4. The modified metabolic environment created by the presence of 2DG was rather quickly changed after cessation of administration, with resumption of tumor growth to a rate approaching that of controls.

* Supported in part by a grant from the California Division, American Cancer Society.

Received 11/20/56.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1957 by the American Association for Cancer Research.